What Is Tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to release the body's own growth hormone, which can subsequently increase insulin-like growth factor-1 (IGF-1). It is one of the most extensively studied GHRH analogues and has approved medical uses for specific indications while also being researched for broader metabolic applications.
How It Works
Tesamorelin binds to GHRH receptors in the pituitary gland, increasing pulsatile growth hormone secretion without directly supplying growth hormone. The resulting increase in GH and IGF-1 influences fat metabolism, protein synthesis, and body composition while preserving the body's natural feedback mechanisms.
Potential Benefits Being Studied
Research has evaluated tesamorelin for reduction of visceral abdominal fat, improvements in body composition, preservation of lean muscle mass, metabolic health, cognitive function, nonalcoholic fatty liver disease, and healthy aging. Evidence is strongest for reduction of visceral adipose tissue in selected patient populations.
Typical Research and Clinical Dosing
Published studies have used once-daily subcutaneous administration. The exact dose depends on the approved indication or research protocol. There is no universal dosing regimen appropriate for every application.
Administration and Timing
Tesamorelin is administered by subcutaneous injection, commonly into the abdomen while rotating injection sites. Many protocols evaluate consistent daily administration at approximately the same time each day.
Possible Side Effects
Reported adverse effects include injection-site reactions, headache, joint discomfort, swelling, muscle aches, nausea, elevated blood sugar, and increases in IGF-1. Allergic reactions are uncommon but have been reported.
Contraindications and Precautions
Tesamorelin should be used cautiously in individuals with active malignancy, uncontrolled endocrine disorders, or significant elevations in IGF-1. Medical evaluation is appropriate before therapies affecting the growth hormone axis are considered.
Bottom Line
Tesamorelin is one of the best-studied GHRH peptides because it stimulates natural growth hormone release rather than replacing growth hormone directly. It continues to be investigated for body composition, metabolic health, and healthy aging while additional research expands understanding of its long-term effects.
Educational Reminder
This document is intended for educational purposes only and should not replace individualized medical advice.